Literature DB >> 15694999

Confirmation of the association of the C4B null allelle in autism.

Dennis Odell1, Alma Maciulis, Adele Cutler, Louise Warren, William M McMahon, Hilary Coon, Gene Stubbs, Kathy Henley, Anthony Torres.   

Abstract

The objective of this study was to examine and attempt to confirm our previous findings of an increased frequency of the C4B null allele (C4BQ0) in subjects with autism. Newly identified subjects from Utah and Oregon were studied. Families evaluated included 85 who had a child with autism and 69 control families. Of the subjects with autism studied, 42.4% carried at least one C4BQ0, compared with 14.5% of the control subjects (p = 0.00013), with a relative risk of 4.33. Over half of the C4B null alleles in the subjects with autism involved C4A duplications. A marked increase in the ancestral haplotype 44.1 that lacks a C4B gene and has 2 C4A genes was also observed. The results of this study suggest that the human leukocyte antigen class III C4BQ0 significantly increases the risk for autism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694999     DOI: 10.1016/j.humimm.2004.11.002

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  39 in total

1.  Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-04-25       Impact factor: 8.322

2.  Assessment of complement C4 gene copy number using the paralog ratio test.

Authors:  Michelle M A Fernando; Lora Boteva; David L Morris; Bi Zhou; Yee Ling Wu; Marja-Liisa Lokki; Chack Yung Yu; John D Rioux; Edward J Hollox; Timothy J Vyse
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

Review 3.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

4.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

Review 5.  The role of immune dysfunction in the pathophysiology of autism.

Authors:  Charity Onore; Milo Careaga; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2011-08-28       Impact factor: 7.217

6.  Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population.

Authors:  Yongmei Lv; Sumin He; Zheng Zhang; Yang Li; Dayan Hu; Kunju Zhu; Hui Cheng; Fusheng Zhou; Gang Chen; Xiaodong Zheng; Pan Li; Yunqing Ren; Xianyong Yin; Yong Cui; Liangdan Sun; Sen Yang; Xuejun Zhang
Journal:  Rheumatol Int       Date:  2011-09-09       Impact factor: 2.631

Review 7.  Immune mediators in the brain and peripheral tissues in autism spectrum disorder.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Nat Rev Neurosci       Date:  2015-08       Impact factor: 34.870

8.  Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism.

Authors:  Anthony R Torres; Jonna B Westover; Cole Gibbons; Randall C Johnson; David C Ward
Journal:  Brain Behav Immun       Date:  2012-08-03       Impact factor: 7.217

9.  Altered gene expression and function of peripheral blood natural killer cells in children with autism.

Authors:  Amanda M Enstrom; Lisa Lit; Charity E Onore; Jeff P Gregg; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto; Judy A Van de Water; Frank R Sharp; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2008-08-14       Impact factor: 7.217

Review 10.  Autoimmunity in autism.

Authors:  Amanda M Enstrom; Judy A Van de Water; Paul Ashwood
Journal:  Curr Opin Investig Drugs       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.